Table II.
Variables | Univariate analysis P-value | Multivariate analysis P-value |
---|---|---|
Age (<60 vs. ≥60 years) | 0.009 | 0.023 |
Gender (female vs. male) | 0.415 | 0.690 |
Histology (NSCLC vs. SCLC) | 0.446 | 0.104 |
Stage of disease (non-metastatic vs. metastatic) | 0.109 | 0.053 |
LDH (<450 vs. ≥450 IU/l) | 0.001 | 0.263 |
Hemoglobin (<12 vs. ≥12 g/dl) | 0.412 | 0.158 |
Leucocyte (<11,000 vs. ≥11,000/mm3) | 0.829 | 0.023 |
Platelet (<350,000 vs. ≥350,000/mm3) | 0.763 | 0.105 |
Sedimentation (<40 vs. ≥40 mm/h) | 0.524 | 0.116 |
Response to chemotherapy (yes vs. no) | <0.001 | 0.004 |
Significant P-values (<0.05) are highlighted in bold. NSCLC, non-small-cell lung cancer; SCLC, small-cell lung cancer; LDH, lactate dehydrogenase.